Sepsis oluşturulan sıçanlarda farklı konsantrasyonlarda verilen albuminin böbrek antioksidan ve serbest oksijen radikalleri üzerine etkisi

Volume: 27 Number: 1 September 30, 2015
  • Özlem Kara
  • Tümay Umuroglu
  • Tolga Gürsoy
  • Kemal Tolga Saraçoğlu
  • Fevzi Yılmaz Goğüs
EN TR

-

Abstract

Objectives: The aim of this study is to investigate the effects of different concentrations of albumin, which has antioxidant characteristics on renal antioxidant levels and renal functions in rats with sepsis.Materials and Methods: Twenty-eight adult male Sprague-Dawley rats were divided into 4 groups. No agent was implemented to Group K. Group S received 30 ml/kg of saline infusion for 90 min, Group A5 received 15 ml/kg of 5% albumin infusion for 90 min and Group A25 received 3 ml/kg of 25% albumin infusion for 45 min. At the end of the 18th hour, bilateral nephrectomy was performed. Blood samples were taken to determine blood urea nitrogen, creatinine and albumin levels. Kidney tissue samples were dissected to measure the levels of free oxygen radicals and antioxidants.Results: Better renal function, higher levels of glutathione and malondialdehyde with lower myeloperoxidase levels were obtained in septic rats following treatment with 2 different concentrations of albumin. In Group A25, blood urea nitrogen and renal glutathione levels were significantly higher than in Group A5. Conclusion: We are of the opinion that the rapid infusion of 25% albumin may prevent or delay the occurrence of renal dysfunction in patients with sepsis.

Keywords

References

  1. 1. Chen YC, Chang SC, Pu C, Tang GJ. The impact of nationwide education program on clinical practice in sepsis care and mortality of severe sepsis: a population-based study in taiwan. PLoS One 2013;8:e77414. doi: 10.1371/journal.pone.0077414.
  2. 2. Trzeciak S, Cinel I, Phillip Dellinger R, et al. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008;15:399-413. doi: 10.1111/j.1553-2712.2008.00109.x.
  3. 3. Bozza FA, D’Avila JC, Ritter C, Sonneville R, Sharshar T, Dal-Pizzol F. Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock 2013;39:10-6. doi: 10.1097/SHK.0b013e31828fade1.
  4. 4. Wang Z, Holthoff JH, Seely KA, et al. Development of oxidative stress in the peritubular capillary microenvironment mediates sepsisinduced renal microcirculatory failure and acute kidney injury. Am J Pathol 2012;180:505-16. doi: 10.1016/j.ajpath.2011.10.011.
  5. 5. Sakaguchi S, Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol 2006;47:167-77.
  6. 6. Rocha M, Herance R, Rovira S, Hernández-Mijares A, Victor VM. Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets 2012;12:161-78.
  7. 7. Lowes DA, Webster NR, Murphy MP, Galley HF. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth 2013;110:472-80. doi: 10.1093/bja/aes577.
  8. 8. Rozga J, Piątek T, Małkowski P. Human albumin: old, new, and emerging applications. Ann Transplant 2013;18:205-17. doi: 10.12659/AOT.889188.

Details

Primary Language

tr.

Subjects

-

Journal Section

-

Authors

Özlem Kara This is me

Tümay Umuroglu This is me

Tolga Gürsoy This is me

Kemal Tolga Saraçoğlu This is me

Fevzi Yılmaz Goğüs This is me

Publication Date

September 30, 2015

Submission Date

February 28, 2014

Acceptance Date

-

Published in Issue

Year 2014 Volume: 27 Number: 1

APA
Kara, Ö., Umuroglu, T., Gürsoy, T., Saraçoğlu, K. T., & Goğüs, F. Y. (2015). -. Marmara Medical Journal, 27(1), 42-46. https://doi.org/10.5472/MMJ.21013.03206.1
AMA
1.Kara Ö, Umuroglu T, Gürsoy T, Saraçoğlu KT, Goğüs FY. -. Marmara Med J. 2015;27(1):42-46. doi:10.5472/MMJ.21013.03206.1
Chicago
Kara, Özlem, Tümay Umuroglu, Tolga Gürsoy, Kemal Tolga Saraçoğlu, and Fevzi Yılmaz Goğüs. 2015. “-”. Marmara Medical Journal 27 (1): 42-46. https://doi.org/10.5472/MMJ.21013.03206.1.
EndNote
Kara Ö, Umuroglu T, Gürsoy T, Saraçoğlu KT, Goğüs FY (September 1, 2015) -. Marmara Medical Journal 27 1 42–46.
IEEE
[1]Ö. Kara, T. Umuroglu, T. Gürsoy, K. T. Saraçoğlu, and F. Y. Goğüs, “-”, Marmara Med J, vol. 27, no. 1, pp. 42–46, Sept. 2015, doi: 10.5472/MMJ.21013.03206.1.
ISNAD
Kara, Özlem - Umuroglu, Tümay - Gürsoy, Tolga - Saraçoğlu, Kemal Tolga - Goğüs, Fevzi Yılmaz. “-”. Marmara Medical Journal 27/1 (September 1, 2015): 42-46. https://doi.org/10.5472/MMJ.21013.03206.1.
JAMA
1.Kara Ö, Umuroglu T, Gürsoy T, Saraçoğlu KT, Goğüs FY. -. Marmara Med J. 2015;27:42–46.
MLA
Kara, Özlem, et al. “-”. Marmara Medical Journal, vol. 27, no. 1, Sept. 2015, pp. 42-46, doi:10.5472/MMJ.21013.03206.1.
Vancouver
1.Özlem Kara, Tümay Umuroglu, Tolga Gürsoy, Kemal Tolga Saraçoğlu, Fevzi Yılmaz Goğüs. -. Marmara Med J. 2015 Sep. 1;27(1):42-6. doi:10.5472/MMJ.21013.03206.1